Orforglipron, the new weight loss pill manufactured by Eli Lilly, helped patients in a recent study lose a significant amount of weight, the company said.

Eli Lilly says their obesity pill led to more than 12% weight loss in closely watched late-stage trial, paving way for approval. Patients taking the pill called orforglipron, an oral GLP-1 receptor, lost almost 12% of their body weight,

In eagerly awaited results from a new study, the pharmaceutical company Eli Lilly reports that a pill its scientists developed causes people who are overweight or obese, but not diabetic, to lose significant amounts of weight.